N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives were design, synthesized and tested for their in vitro antimycobacterial activity. The new compounds showed a moderate antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H37Ra and a significant antimycobacterial activity against several mycobacteria other than tuberculosis strains.

Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives

ZAMPIERI, DANIELE;MAMOLO, MARIA GRAZIA;VIO, LUCIANO;ROMANO, MAURIZIO;
2016-01-01

Abstract

N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives were design, synthesized and tested for their in vitro antimycobacterial activity. The new compounds showed a moderate antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H37Ra and a significant antimycobacterial activity against several mycobacteria other than tuberculosis strains.
File in questo prodotto:
File Dimensione Formato  
BMCL-2016.pdf

Accesso chiuso

Descrizione: Main text
Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 309.96 kB
Formato Adobe PDF
309.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Supplementary information -DZ-rev2.pdf

Accesso chiuso

Descrizione: Supplementary information
Tipologia: Altro materiale allegato
Licenza: Copyright Editore
Dimensione 346.55 kB
Formato Adobe PDF
346.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2875602
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact